PSTV icon

Plus Therapeutics
PSTV

Overview Fund Activity

23 hedge funds and large institutions have $3.26M invested in Plus Therapeutics in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.

Holders
23
Holders Change
-1
Holders Change %
-4.17%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PHP
1
Parkman Healthcare Partners
Connecticut
$1.53M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$855K
3
Morgan Stanley
3
Morgan Stanley
New York
$123K
4
OCA
4
Otter Creek Advisors
Florida
$84K
5
BlackRock
5
BlackRock
New York
$146K

Top Sellers

1
Two Sigma Advisers
1
Two Sigma Advisers
New York
$79K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$67K
3
Two Sigma Investments
3
Two Sigma Investments
New York
$0
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Barclays
26
Barclays
United Kingdom
$0 1 +1 New
UB
27
UMB Bank
Missouri
$0 46 +12 +35%
Wells Fargo
28
Wells Fargo
California
$0 131 +35 +36%
1
2